Gene Writers™
: a genome engineering technology based on mobile genetic elements that consists of a protein and an RNA or DNA template to effect a therapeutic change
Video 07.10.2024
Noubar Afeyan, Flagship Founder & CEO, discusses Flagship's capital raise of $3.6 billion to support the creation and development of breakthrough companies in human health, sustainability, and artificial intelligence. For more on Flagship's recent advances including key partnerships, global expansion and expanded top talent, read the full announcement.